FDA Approves Once-Daily Mirapex ER for the Treatment of Early Parkinson’s Disease
Research Ties Diabetes Drug to Heart Woes – Feb. 20
GSK Defends Diabetes Drug as Avandia is Attacked Again in US
MediGene and Teva Sign Agreement To Commercialize Veregen in Israel
Novartis’ Menveo Gets OK and FDA Gives Priority To Oral MS Drug
Despite Price Cuts, Philippines is Attractive Market For Pharma
SUBSCRIBE